Hepatocellular carcinoma treated by sorafenib with complete radiological response according to mRECIST criteria: Could we stop the treatment? About four cases

Authors

  • Florian Poullenot Department of Gastroenterology and Hepatology, Saint-André Hospital, University Hospital of Bordeaux and Victor Segalen University, Bordeaux, France
  • Paulette Bioulac-Sage Department of Pathology, Pellegrin Hospital, University Hospital of Bordeaux and Victor Segalen University, Bordeaux, France
  • Hervé Laumonier Department of Radiology, Saint André Hospital, University Hospital of Bordeaux, and Victor Segalen University, Bordeaux, France
  • Jean Saric Department of Digestive Surgery, Saint André Hospital, University Hospital of Bordeaux and Victor Segalen University, Bordeaux, France
  • Thibault Carteret Department of Radiology, Saint André Hospital, University Hospital of Bordeaux, and Victor Segalen University, Bordeaux, France
  • Jean-Frédéric Blanc Department of Gastroenterology and Hepatology, Saint-André Hospital, University Hospital of Bordeaux and Victor Segalen University, Bordeaux, France

DOI:

https://doi.org/10.3109/0284186X.2013.795286

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2014-03-01

How to Cite

Poullenot, F., Bioulac-Sage, P., Laumonier, H., Saric, J., Carteret, T., & Blanc, J.-F. (2014). Hepatocellular carcinoma treated by sorafenib with complete radiological response according to mRECIST criteria: Could we stop the treatment? About four cases. Acta Oncologica, 53(3), 420–423. https://doi.org/10.3109/0284186X.2013.795286

Issue

Vol. 53 No. 3 (2014): Acta Oncologica

Section

Articles